Key result
Plant food-derived peptides demonstrate antihypertensive potential through ACE inhibition across preclinical studies.
Hypertension is one of the most common worldwide diseases that afflict humans. Angiotensin I converting enzyme (ACE) catalyzes the formation of vasoconstrictor, angiotensin II, and the inactivation of vasodilator, bradykinin. The influences of ACE on blood pressure make it an ideal target clinically and nutritionally in the treatment of hypertension. A number of animal food-derived peptides have been reviewed about their in vitro and in vivo ACE inhibitory activities. The aim of this review is to discuss the plant food-derived angiotensin I converting enzyme (ACE) inhibitory peptides from sources, production, purification, and structure to in vitro and in vivo activities.
No takes yet. Share an insight, caveat, or question.
Guang et al. (2009) conducted a review in Hypertension. Plant food-derived angiotensin I converting enzyme (ACE) inhibitory peptides was evaluated. Plant food-derived angiotensin I converting enzyme (ACE) inhibitory peptides are reviewed regarding their sources, production, purification, structure, and in vitro and in vivo activities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: